Patent · US Active

TRPA1 antagonists

US9108905B2 · kind B2 · utility

0Cited by

1References

4Claims

0Family size

Assignee

Abb Vie Inc. · US

Inventors

Richard J. Perner · Gurnee, US
Michael E. Kort · Lake Bluff, US
Stanley DiDomenico · Richmond, US
Jun Chen · Lake Bluff, US
Anil Vasudevan · Union Grove, US

Key dates

Filing date	Jan 2, 2009
Grant date	Aug 18, 2015
Priority date	—
Expiry date	Jan 9, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C251/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formula (I)wherein R1, R2, R3, m, and Y are defined in the specification are TRPA1 antagonists. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.